NKTR-255 enhances complete response following CD19 CAR T-cell therapy in patients with relapsed/refractory large B-cell lymphoma.

ABSTRACT:

SUBMITTER: Ahmed S 

PROVIDER: S-EPMC12719151 | biostudies-literature | 2025 Dec

REPOSITORIES: biostudies-literature